NCT06482684View on ClinicalTrials.gov

CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

June 15, 2031

Study Completion Date

December 31, 2031

Conditions
Mantle Cell Lymphoma
Interventions
DRUG

KTE-X19

See description of treatment arms

DRUG

Ibrutinib

See description of treatment arms

Trial Locations (2)

81377

RECRUITING

Klinikum der Universität München, Munich

Unknown

RECRUITING

University Hospital of Mainz, Mainz

All Listed Sponsors
collaborator

Johannes Gutenberg University Mainz

OTHER

lead

Christian Schmidt, MD

OTHER